Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neurovascular Embolization Devices, Neurovascular Accessory Devices Neurovascular Coiling Assist Devices, Neurovascular Thrombectomy Devices and Intracranial Stents are the segments covered under this category. Intracranial Stents are used to expand walls of a narrowed vessel in the brain due to intracranial atherosclerotic disease – the cumulation of fat and plaque on blood vessel walls. GlobalData uses proprietary data and analytics to provide a comprehensive report on the intracranial stents devices market, including market shares of different players within China. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the intracranial stents market in China was MicroPort Scientific and Stryker.
Severe intracranial stenosis can lead to ischemic strokes as embolic can become lodged in the area.
The value of the intracranial stents devices market within China was expected to be over $10m in 2023.
For the latest complete market share analysis of intracranial stents device market in China, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
